Form 4 for AXGN Axogen, Inc.
Accepted 2026-03-02 00:00:00 ET · period of report 2026-02-26 · accession 0000805928-26-000044 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2026-03-02 | 2026-02-26+ | AXGN | Kemp Jens | CMO | F - Tax | $31.70 | -18.4K | 76.5K | -19% | -$582.2K |
| D | 2026-03-02 | 2026-02-26 | AXGN | Kemp Jens | CMO | A - Grant | $0.00 | +50.7K | 94.8K | +115% | $0 |
| D | 2026-03-02 | 2026-02-26 | AXGN | Kemp Jens | CMO | A - Grant | $0.00 | +23.0K | 23.0K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-02-26 | F | D | 15,414 | $31.90 | 79,403 | D | — | — | (F4) No shares were sold by the reporting person. The transaction disclosed represents shares of the issuer's Common Stock withheld by the issuer in payment of the withholding tax liability incurred upon the vesting of performance stock units ("PSUs"). |
| 2 | Common | Common Stock | 2026-02-26 | A | A | 50,670 | $0.00 | 94,817 | D | — | — | (F1) This reflects the number of shares that became vested as of February 26, 2026, upon the attainment and certification of certain performance criteria. (F2) The previous Form 4 filed by the Reporting Person overstated the number of shares beneficially owned by the Reporting Person by 4,003 shares of Common Stock. The amount reported herein has been corrected. (F3) Includes 2,120 shares acquired under the Axogen Employee Stock Purchase Plan on December 31, 2025. |
| 3 | Common | Common Stock | 2026-03-01 | F | D | 2,952 | $30.65 | 76,451 | D | — | — | (F5) No shares were sold by the reporting person. The transaction disclosed represents shares of the issuer's Common Stock withheld by the issuer in payment of the withholding tax liability incurred upon the vesting of restricted stock units ("RSUs"). |
| 4 | Derivative | Restricted Stock Units | 2026-02-26 | A | A | 23,000 | $0.00 | 23,000 | D | — · — to — | 23,000 Common Stock | (F6) Each restricted stock unit represents a contingent right to receive one share of Axogen, Inc. common stock. (F7) All shares of Axogen Inc. common stock underlying the restricted stock units will be fully vested on February 26, 2030 (4 years from the grant date) based upon a vesting schedule whereby 50% of the aggregate shares vest on February 26, 2028 (24 months from the grant date) and an additional 25% of the aggregate shares vest each 12 months thereafter. Vested shares will be delivered to the reporting person upon the vesting date. |